InSite Exchange™—the Impetus InSite Platform®'s asynchronous discussion forum and most popular tool—allows advisors to reply to your most important questions and their peers' responses on their own time within a specified period. When another advisor replies to a comment, an automatic email is sent to the author of the original comment, prompting the advisor to log in and reply back. Others' responses can be made visible to all advisors directly or, to avoid bias and groupthink, be hidden until after the advisor has answered the question first. To improve overall interactivity, advisor moderators can be added and/or the Impetus Forced Reply feature can be leveraged.
Features, Benefits, and How Our Clients Use This…
Advisory boards, working groups, and steering committees
The advisors can respond to questions and comments at the time and place that suit them best
“Instant translation” feature for comments written in another language — perfect for multilingual and international engagements!
Speech-to-text allows participants to dictate their answers instead of typing
Relevant Customer Success Stories
Patient Advocate Engagement: A Customer Story
Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
Case Study: Reducing the Environmental Impact of Pharmaceutical Advisory Boards
Patient Clinical Trial & Communications Plan Review: A Customer Story
Patient Support Program (PSP) Optimization: A Customer Story
Virtual Patient Steering Committee: A Customer Story
Virtual Patient Engagement Program: A Customer Story
Virtual Steering Committee & Peer Influence Program: A Customer Story
Online Learning Portal on the Impetus InSite Platform®: A Customer Story
Internal Brand Planning Sessions on the Impetus InSite Platform®: A Customer Story
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.